What is Ilyang Pharmaceutical Co.,Ltd's (007570.KS) StockRank?

MoatMap's StockRank for Ilyang Pharmaceutical Co.,Ltd (007570.KS) is 43/100, with a Hold signal. This is a composite score combining Quality (48), Value (58), and Momentum (27) factor ranks across MoatMap's 20,000+ stock universe.

Does Ilyang Pharmaceutical Co.,Ltd have an economic moat?

Ilyang Pharmaceutical Co.,Ltd (007570.KS) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Ilyang Pharmaceutical Co.,Ltd a buy, hold, or sell?

MoatMap's current signal for Ilyang Pharmaceutical Co.,Ltd (007570.KS) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Ilyang Pharmaceutical Co.,Ltd in?

Ilyang Pharmaceutical Co.,Ltd (007570.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

007570.KS

HOLDREMOVE

Ilyang Pharmaceutical Co.,Ltd · Healthcare · South Korea · $92M · Avg Vol: $309K/d

StockRank

P/E (TTM)

20.6x

ROE

8.1%

D/E

0.4x

Dividend %

2.0%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Ilyang Pharmaceutical is a mid-sized South Korean pharmaceutical company. It lacks the global distribution scale, blockbuster drug pipeline, and high-margin CDMO characteristics needed to fit our healthcare thesis.

COMPANY DESCRIPTION

Ilyang Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company engaged in the development, production, and marketing of innovative drugs, vaccines, and consumer health products. The company is notable for developing its own proprietary treatments, including Noltec for acid-related disorders and Supect for chronic myeloid leukemia. Ilyang's competitive advantage lies in its proven R&D capabilities, a strong portfolio of self-developed novel drugs, and its expanding export footprint in emerging markets.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	161.4M	173.7M	175.0M	177.4M	3.2%
EPS	0.68	-0.09	0.32	0.24	-28.9%
Shares	19.1M	19.1M	19.1M	17.9M	-6.1%
Debt	48.3M	47.3M	70.1M	82.6M	19.6%
Equity	152.7M	147.7M	153.7M	154.7M	0.5%
Op CF	3.8M	9.5M	3.7M	7.8M	27.0%
Inv CF	15.7M	-7.5M	-24.2M	-4.7M	—
Fin CF	-20.8M	-4.5M	21.0M	9.5M	—

PRICE (1Y)-25.6%

SMA 50SMA 200

$4.80

RSI (14)

39.3

52W High

$10.58

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

5.7%59.2

ROE

8.1%66.4

GP/Assets

23.5%53.7

Op. Margin

-11.3%29.2

FCF/Assets

2.2%58.2

Piotroski

666.7

Int. Cover

5.4x51.7

D/E Ratio

0.44x34.9

Current Ratio

0.93x8.3

Value

P/E (TTM)

20.6x55.8

EV/EBITDA

81.5x6.8

P/FCF

13.5x74.4

P/B

0.6x94.1

P/S

0.5x92.7

Div Yield

2.0%49.7

Momentum

52W High %

45%21.5

RS 6M

-147%2.8

SMA 50/200

0.80x15.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

375%94.7

FUNDAMENTALS

Market Cap

$92M

P/E (Forward)

—

Gross Margin

40.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 007570.KS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
007570.KS	Ilyang Pharmaceutical Co.,Ltd(you)	$92M	43	HOLD
003120.KS	Ilsung Is Co., Ltd.	$91M	47	HOLD
176750.KQ	DuChemBIO Co.,Ltd.	$110M	46	HOLD
102460.KS	REYON Pharmaceutical Co., Ltd.	$118M	38	HOLD
271980.KS	Jeil Pharmaceutical Co.,Ltd	$98M	55	HOLD
000230.KS	Ildong Holdings Co., Ltd.	$57M	48	HOLD
002720.KS	Kukje Pharma Co., Ltd.	$55M	47	HOLD
003220.KS	Daewon Pharmaceutical Co., Ltd.	$116M	28	SELL
293480.KS	Hana Pharm Co., Ltd.	$103M	61	HOLD
214390.KS	Kyongbo Pharmaceutical Co., Ltd	$79M	23	SELL

Peer medians: ROE 0.1% · P/E 16.1x · Gross margin 43.8%

Ilyang Pharmaceutical Co.,Ltd (007570.KS) — Stock Score Summary

Ilyang Pharmaceutical Co.,Ltd (007570.KS) has a MoatMap StockRank of 43/100 based on Quality (48/100), Value (58/100), and Momentum (27/100) factor scores. The current signal is HOLD. Ilyang Pharmaceutical is a mid-sized South Korean pharmaceutical company. It lacks the global distribution scale, blockbuster drug pipeline, and high-margin CDMO characteristics needed to fit our healthcare thesis.

Key Financial Metrics

Price	$4.80
Market Cap	$92M
P/E (TTM)	20.56
Price/Book	0.58
Return on Equity	8.1%
Return on Invested Capital	5.7%
Debt/Equity	43.74
Gross Margin	40.7%
Operating Margin	-11.3%
Revenue Growth	5.0%
Dividend Yield	2.0%
Free Cash Flow	$7M

Ilyang Pharmaceutical Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Ilyang Pharmaceutical Co.,Ltd’s (007570.KS) StockRank?: MoatMap’s StockRank for Ilyang Pharmaceutical Co.,Ltd (007570.KS) is 43/100, with a Hold signal. It is a composite of Quality (48), Value (58), and Momentum (27) factor ranks across MoatMap’s 20,000+ stock universe.
Does Ilyang Pharmaceutical Co.,Ltd have an economic moat?: Ilyang Pharmaceutical Co.,Ltd (007570.KS) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ilyang Pharmaceutical Co.,Ltd a buy, hold, or sell?: MoatMap’s current signal for Ilyang Pharmaceutical Co.,Ltd (007570.KS) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ilyang Pharmaceutical Co.,Ltd in?: Ilyang Pharmaceutical Co.,Ltd (007570.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).